Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma (Q33337313)
scientific article
Language:
Current Data About Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma
(P31) (Q13442814)
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P304) 2679-2686
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P407) (Q1860)

(P433) 10
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P478) 19
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P577) Tuesday, May 1, 2001
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P921) (Q42824440)

(Q356033)
(P887)

(Q18556189)
(P887)

(Q412415)
(P887)

(Q238512)
(P887)

(P1433) (Q400292)
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P1476) "Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma" (language: en)
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

(P2093) M Reni
(P1545) 1
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

P Passoni
(P1545) 2
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

M G Panucci
(P1545) 3
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

R Nicoletti
(P1545) 4
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

L Galli
(P1545) 5
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

G Balzano
(P1545) 6
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

A Zerbi
(P1545) 7
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

V Di Carlo
(P1545) 8
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

E Villa
(P1545) 9
(P248)
(P698) 11352960
(P813) Tuesday, July 25, 2017

other details
description scientific article

External Links
(P356) 10.1200/JCO.2001.19.10.2679
(P698) 11352960